Combretum fruticosum
Combretum fruticosum
Combretum fruticosum is a plant traditionally not well-documented, though it has been observed in various ecological and biological studies. It has shown significant angiotensin-converting enzyme inhibition among tested plants, which may have implications for cardiovascular health. (-)-Trachelogenin from this plant demonstrated cytotoxicity against certain tumor cell lines but had no effect on non-tumor cells, indicating potential anti-cancer properties. Additionally, its seedlings exhibited varied photosynthetic and morphological responses to light changes, showing both immediate and carryover effects. Notably, the nectar of Combretum fruticosum was more frequently consumed by critically endangered cotton-top tamarins during dry seasons based on 22 years of feeding data from Colombia. Safety records for this plant are currently unremarkable, with no major issues reported. There is also no recorded evidence of significant drug interactions.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- (-)-Trachelogenin showed cytotoxicity against certain tumor cell lines but not non-tumor cells, inducing autophagic cell death.
- Combretum fruticosum showed significant angiotensin-converting enzyme inhibition among plants tested.
- Combretum fruticosum nectar consumption peaked in November, contributing to the tamarins' varied diet.
- Photosynthetic and morphological responses to light changes varied among seedlings of different species, showing some carryover effects and species-specific plasticity.
Frequently asked questions
What is Combretum fruticosum?
Combretum fruticosum (Combretum fruticosum) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Combretum fruticosum?
4 sourced findings are recorded for Combretum fruticosum; the strongest carries evidence grade D. For example: (-)-Trachelogenin showed cytotoxicity against certain tumor cell lines but not non-tumor cells, inducing autophagic cell death.
How strong is the evidence for Combretum fruticosum?
The strongest finding for Combretum fruticosum carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Combretum fruticosum safe? What are the side effects?
No major safety issues are recorded for Combretum fruticosum in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Combretum fruticosum interact with medications?
No drug interactions are recorded for Combretum fruticosum in our sources. This does not rule them out — check with a pharmacist.
Is Combretum fruticosum a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 Angiotensin-converting enzyme inhibition by Brazilian plants. literature abstract metadata
- T2 Photosynthetic and morphological acclimation of seedlings of tropical lianas to changes in the light environment. literature abstract metadata
- T2 In vitro antitumor effect of a lignan isolated from Combretum fruticosum, trachelogenin, in HCT-116 human colon cancer cells. literature abstract metadata
- T2 The impacts of seasonal variation and climate on food utilization in a population of critically endangered cotton-top tamarins (Saguinus oedipus) in Colombia: A 22-year longitudinal study. literature abstract metadata